Skip to content

Clinical trials

Phase 3 Virus Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Virus Diseases Phase: Phase 3 Country / region: United Kingdom Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20171
20203
20213
20221
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)5
ModernaTX, Inc.4
AstraZeneca1
Gilead Sciences1
Janssen-Cilag International NV1
Medicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Virus Diseases13
COVID-197
Coronavirus Infections7
RNA Virus Infections7
Severe Acute Respiratory Syndrome6
Coronaviridae Infections5
Nidovirales Infections5
Infections3
Influenza, Human3
Respiratory Tract Infections2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.